Kennedy JL - Search Results

1

Review and Consensus on Pharmacogenomic Testing in Psychiatry.

Bousman CA, Bengesser SA, Aitchison KJ, Amare AT, Aschauer H, Baune BT, Asl BB, Bishop JR, Burmeister M, Chaumette B, Chen LS, Cordner ZA, Deckert J, Degenhardt F, DeLisi LE, Folkersen L, Kennedy JL, Klein TE, McClay JL, McMahon FJ, Musil R, Saccone NL, Sangkuhl K, Stowe RM, Tan EC, Tiwari AK, Zai CC, Zai G, Zhang J, Gaedigk A, Müller DJ. Bousman CA, et al. Among authors: kennedy jl. Pharmacopsychiatry. 2021 Jan;54(1):5-17. doi: 10.1055/a-1288-1061. Epub 2020 Nov 4. Pharmacopsychiatry. 2021. PMID: 33147643

2

The 5HT1Dbeta receptor gene in bipolar disorder: a family-based association study.

Mundo E, Zai G, Lee L, Parikh SV, Kennedy JL. Mundo E, et al. Among authors: kennedy jl. Neuropsychopharmacology. 2001 Oct;25(4):608-13. doi: 10.1016/S0893-133X(01)00259-7. Neuropsychopharmacology. 2001. PMID: 11557174 Clinical Trial.

3

5HT1Dbeta Receptor gene implicated in the pathogenesis of Obsessive-Compulsive Disorder: further evidence from a family-based association study.

Mundo E, Richter MA, Zai G, Sam F, McBride J, Macciardi F, Kennedy JL. Mundo E, et al. Among authors: kennedy jl. Mol Psychiatry. 2002;7(7):805-9. doi: 10.1038/sj.mp.4001059. Mol Psychiatry. 2002. PMID: 12192628

4

Clinical implications of pharmacogenomics for tardive dyskinesia.

Müller DJ, Shinkai T, De Luca V, Kennedy JL. Müller DJ, et al. Among authors: kennedy jl. Pharmacogenomics J. 2004;4(2):77-87. doi: 10.1038/sj.tpj.6500233. Pharmacogenomics J. 2004. PMID: 15042144 Review. No abstract available.

5

Evidence of association between smoking and alpha7 nicotinic receptor subunit gene in schizophrenia patients.

De Luca V, Wong AH, Muller DJ, Wong GW, Tyndale RF, Kennedy JL. De Luca V, et al. Among authors: kennedy jl. Neuropsychopharmacology. 2004 Aug;29(8):1522-6. doi: 10.1038/sj.npp.1300466. Neuropsychopharmacology. 2004. PMID: 15100704

6

Pharmacogenetics of antipsychotic-induced weight gain.

Müller DJ, Muglia P, Fortune T, Kennedy JL. Müller DJ, et al. Among authors: kennedy jl. Pharmacol Res. 2004 Apr;49(4):309-29. doi: 10.1016/j.phrs.2003.05.001. Pharmacol Res. 2004. PMID: 15202511 Review.

7

Myelin oligodendrocyte glycoprotein (MOG) gene is associated with obsessive-compulsive disorder.

Zai G, Bezchlibnyk YB, Richter MA, Arnold P, Burroughs E, Barr CL, Kennedy JL. Zai G, et al. Among authors: kennedy jl. Am J Med Genet B Neuropsychiatr Genet. 2004 Aug 15;129B(1):64-8. doi: 10.1002/ajmg.b.30077. Am J Med Genet B Neuropsychiatr Genet. 2004. PMID: 15274043

8

Genetic study of the myelin oligodendrocyte glycoprotein (MOG) gene in schizophrenia.

Zai G, King N, Wigg K, Couto J, Wong GW, Honer WG, Barr CL, Kennedy JL. Zai G, et al. Among authors: kennedy jl. Genes Brain Behav. 2005 Feb;4(1):2-9. doi: 10.1111/j.1601-183X.2004.00089.x. Genes Brain Behav. 2005. PMID: 15660663 Free article. Clinical Trial.

9

Evidence for the gamma-amino-butyric acid type B receptor 1 (GABBR1) gene as a susceptibility factor in obsessive-compulsive disorder.

Zai G, Arnold P, Burroughs E, Barr CL, Richter MA, Kennedy JL. Zai G, et al. Among authors: kennedy jl. Am J Med Genet B Neuropsychiatr Genet. 2005 Apr 5;134B(1):25-9. doi: 10.1002/ajmg.b.30152. Am J Med Genet B Neuropsychiatr Genet. 2005. PMID: 15685626

10

Possible association between the gamma-aminobutyric acid type B receptor 1 (GABBR1) gene and schizophrenia.

Zai G, King N, Wong GW, Barr CL, Kennedy JL. Zai G, et al. Among authors: kennedy jl. Eur Neuropsychopharmacol. 2005 May;15(3):347-52. doi: 10.1016/j.euroneuro.2004.12.006. Eur Neuropsychopharmacol. 2005. PMID: 15820424

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

989 results

Search Page